Light-based blood test for lung cancer detection
Part of Cancer clinical trials.
This study uses a special light-based blood test to tell the difference between benign (non-cancerous) and malignant (cancerous) growths in the lungs. It aims to help doctors diagnose lung cancer more accurately and earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a lung cancer diagnosis that is confirmed by your doctor.
- You need to be willing to take part and follow the study plan.
- You (or someone legally acting for you) must sign a consent form approved by the hospital's ethics committee.
- You cannot have any other type of cancer.
- You should not have severe lung diseases like COPD, asthma, or bronchiectasis, and no history of significant dust, mine, or asbestos exposure.
- Your basic medical history and test results must be available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that can find EGFR gene changes (mutations) in people with advanced lung cancer. The test may help doctors choose better treatments by detecting these mutations more easily and accurately.
This study is testing a new blood test that uses a special light-based method to detect lung cancer by looking at molecules in your blood. It may help tell if a lung nodule is cancerous without needing more invasive procedures.
This study tests a new blood test that may help find out if lung cancer has spread to other parts of the body. It uses a special technology to analyze your blood and might give doctors more information to guide your care.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study is testing a new blood test that uses a special light-based method to help identify types of lung cancer. The test looks at tiny particles in your blood to help doctors understand your cancer better.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
Hear when a new Lung Cancer in Normal and Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.